Drug recall · January 10, 2018
Zoloft (sertraline HCl) tablets 25 mg* recall
Why: SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Zoloft (sertraline HCl) tablets 25 mg* 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., NY, NY, 10017 NDC 0049-4960-30
- Lots / codes
Lot: S84026
- Quantity
- 1972 bottles
- Company
- Pfizer Inc., New York, NY
- Distribution
- Nationwide in the USA
- Initiated
- October 20, 2017 · Voluntary: Firm initiated
- Classified
- January 4, 2018
- Reported
- January 10, 2018
- Ended
- June 2, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sertraline
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.